Bizily Scott
CIK 1920738
Transactions on file
25
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-20 | 2026-10-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $21.0K | -7.3% | open → |
| 2026-10-20 | 2026-10-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2026-09-22 | 2026-09-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $22.3K | -12.8% | open → |
| 2026-09-22 | 2026-09-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2026-09-03 | 2026-09-01 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 584 | $8.2K | -15.0% | open → |
| 2026-09-03 | 2026-09-01 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 584 | $3.8K | +83.4% | open → |
| 2026-08-17 | 2026-08-17 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $19.9K | -2.5% | open → |
| 2026-08-17 | 2026-08-17 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2026-08-17 | 2026-08-13 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $19.6K | -0.8% | open → |
| 2026-08-17 | 2026-08-13 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2026-07-02 | 2026-06-30 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 6,566 | $91.9K | -15.0% | open → |
| 2026-07-02 | 2026-06-30 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 5,752 | $37.3K | +83.4% | open → |
| 2026-07-02 | 2026-06-30 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 814 | $3.4K | +187.4% | open → |
| 2026-06-25 | 2026-06-23 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 9,810 | $117.7K | -0.8% | open → |
| 2026-06-25 | 2026-06-23 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 9,810 | $40.6K | +187.4% | open → |
| 2025-12-19 | 2025-12-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $17.8K | +9.2% | open → |
| 2025-12-19 | 2025-12-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2025-11-19 | 2025-11-17 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $17.3K | +12.4% | open → |
| 2025-11-19 | 2025-11-17 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2025-10-27 | 2025-10-24 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 2,678 | $32.1K | -0.8% | open → |
| 2025-10-27 | 2025-10-24 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,084 | $7.0K | +83.4% | open → |
| 2025-10-20 | 2025-10-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 1,635 | $16.6K | +17.0% | open → |
| 2025-10-20 | 2025-10-16 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Exer. | 1,635 | $6.8K | +187.4% | open → |
| 2025-10-14 | 2025-10-09 | FDMT 4D Molecular Therapeutics, Inc. | Chief Legal Officer | Sale | 2,408 | $24.1K | +19.0% | open → |
| 2025-09-26 | 2025-09-23 | FDMT 4D Molecular Therapeutics, Inc. | Officer Chief Legal Officer | Sale | 2,407 | $19.3K | +48.8% | open → |
